Convertible Stock List (Part 4) [Parabolic Signal Convertible Stock List]

○List of sales conversion stocks market code stock name closing price SAR Tokyo Stock Exchange Prime ＜1959＞ Kyudenko 6955 7132 ＜2651＞ Lawson 10340 10365 ＜3031＞ Raccoon HD 653 680 ＜3048＞ Bic Camera 1549 1648 ＜3328＞ BEENOS 2135 2294 ＜4004＞ 　

Fisco JapanApr 24 18:55 ET

Bic Camera's Shares Jump After It Projects Net Profit Will Triple This Fiscal Year

By Kosaku Narioka Bic Camera's shares rose sharply after it forecast net profit would triple this fiscal year, due partly to a projected increase in sales to foreign travelers to Japan. Shares were

WSJApr 14 22:12 ET

4/15 [Today's Investment Strategy]

[FISCO Specially Selected Brand] [Material Brand] Doutor Nichires Holdings ＜3087＞ 2057 yen (4/12) will develop Doutor Coffee Shop, Hoshino Coffee Shop, Yomenya Goemon, etc. Financial results for the fiscal year ended February 24 were announced. Operating profit was 7.332 billion yen (2.4 times the previous fiscal year). Starting with the introduction and renewal of new products in each business category, we continued activities to tackle the COVID-19 pandemic, such as expanding takeout menus and kiosk products, and expanding the wholesale business. Operating profit for the fiscal year ending 25/2

Fisco JapanApr 14 20:09 ET

Pay attention to Takashimaya and Terrace Sky, are Pasona and S-Pool doing well

On the US stock market on the 12th of last weekend, the NY Dow depreciated 475.84 dollars to 37,983.24, the Nasdaq Composite Index fell 267.11 points to 16,175.09, and the Chicago Nikkei 225 futures were 38865 yen, 685 yen lower than the Osaka Japan-China ratio. The exchange rate is 1 dollar = 153.10-20 yen. In today's Tokyo market, Ringer Hutt (8200) announced that operating profit turned into a surplus for the previous fiscal year and a 49.3% increase forecast for the current fiscal year, and Doutor Day Less announced that operating profit was 2.4 times the previous fiscal year and 32.2% increase forecast for the current fiscal year <

Fisco JapanApr 14 19:15 ET

Astellas Pharmaceuticals, 24/3 revised downward operating profit 13 billion yen ← 83 billion yen

Astellas Pharmaceuticals ＜4503＞ announced revisions to its earnings forecast for the fiscal year ending 2024/3. Operating profit was revised downward from 83 billion yen to 13 billion yen. As a result of reviewing the asset value of the gene therapy program AT808, which is undergoing research and development for Friedreich ataxia patients, impairment losses of approximately 40 billion yen of intangible assets related to AT808 will be recorded as other expenses. [Positive Evaluation] ＜8233＞Takashimaya Full Year | ＜6432＞Takeuchi Production

Fisco JapanApr 14 17:23 ET

Bic Camera's Attributable Profit Soars 32% in Fiscal H1

Bic Camera's (TYO:3048) profit attributable to owners of the parent soared 32.1% to 5.55 billion yen in the fiscal six months ended Feb. 29, from 4.2 billion yen a year ago mainly due to higher sales.

MT NewswiresApr 12 06:56 ET